Another promise against ischemia reperfusion injury: every success raises new questions

about

At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.

P2860

Q37570347-6B16FACF-8DB9-4F7A-B996-E8FC1E67D108

P2860

Another promise against ischemia reperfusion injury: every success raises new questions

Item

http://www.wikidata.org/entity/Q42370331

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Another promise against ischemia reperfusion injury: every success raises new questions

@en

Another promise against ischemia reperfusion injury: every success raises new questions

@nl

type

Item

label

Another promise against ischemia reperfusion injury: every success raises new questions

@en

Another promise against ischemia reperfusion injury: every success raises new questions

@nl

prefLabel

Another promise against ischemia reperfusion injury: every success raises new questions

@en

Another promise against ischemia reperfusion injury: every success raises new questions

@nl

P1476

Another promise against ischemia reperfusion injury: every success raises new questions

@en

P2093

Dennis V Cokkinos

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration

Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in

Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction

Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats.

HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway.

Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.

Plasma miR-208 as a biomarker of myocardial injury.

ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion.

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/ATM.2016.08.33

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27867971

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

P932

5104652

http://www.w3.org/2001/XMLSchema#string

Another promise against ischemia reperfusion injury: every success raises new questions

about

P2860

P2860

Another promise against ischemia reperfusion injury: every success raises new questions

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932